GCG and diabetes mellitus: Exendin-4, an analog of the incretin GLP-1 used to treat diabetes, prevents the systolic dysfunction in HFD-fed mice, also reduces the markers of pyroptosis, such as caspase-1 activation and IL-1β and IL-18 release, in mice cardiomyocytes exposed to high glucose (33).